Pubblicazioni

Outcomes According to Coronary Revascularization Modality in theÂ ISCHEMIA Trial

2024 - JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Redfors, Bjorn; Stone, Gregg W.; Alexander, John H.; Bates, Eric R.; Bhatt, Deepak L.; Biondi-Zoccai, Giuseppe; Caldonazo, Tulio; Farkouh, Michael; Rahouma, Mohamed; Puskas, John; Sandner, Sigrid; Gaudino, Mario F. L.

Correction (Journal of the American College of Cardiology (2021) 77(2) (173â185), (S0735109720378694), (10.1016/j.jacc.2020.10.054)

2021 - JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Einstein, A; Shaw, L; Hirschfeld, C; Williams, M; Villines, T; Better, N; Vitola, J; Cerci, R; Dorbala, S; Raggi, P; Choi, A; Lu, B; Sinitsyn, V; Sergienko, V; Kudo, T; Norgaard, B; Maurovich-Horvat, P; Campisi, R; Milan, E; Louw, L; Allam, A; Bhatia, M; Malkovskiy, E; Goebel, B; Cohen, Y; Randazzo, M; Narula, J; Pascual, Tnb; Pynda, Y; Dondi, M; Frantellizzi, V; De Vincentis, G; Paez, D

Ricerc@Sapienza

Pubblicazioni

Outcomes According to Coronary Revascularization Modality in theÂ ISCHEMIA Trial

Correction (Journal of the American College of Cardiology (2021) 77(2) (173â185), (S0735109720378694), (10.1016/j.jacc.2020.10.054)

Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?

Rapid Deployment But Not Hasty Conclusions

Reply: Apixaban Dosing in Chronic KidneyÂ Disease: Differences Between U.S. andÂ E.U. Labeling

Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry

Reply: Platelet ACTIVATION and PNEUMONIA: Is soluble P-selectin the right marker?

Reply: myocardial infarction in patients with pneumonia

Reply: platelets interplay between pneumonia and cardiovascular events: establishing a link?